Intellia Therapeutics (NTLA) Prices 5.48M Share Common Offering at $18.25/Sh

Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced today the pricing of an underwritten public offering of 5,479,453 shares of its common stock at a public offering price of $18.25 per share. Intellia also granted the underwriters a 30-day option to purchase up to an additional 821,917 shares of its common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $100 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares in the offering are to be sold by Intellia.

Goldman Sachs & Co. LLC, Jefferies and SVB Leerink are acting as joint book-running managers for the offering. The offering is expected to close on or about June 5, 2020, subject to customary closing conditions.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• Goldman Sachs relays thoughts on AI from field work
• Jefferies Reiterates Buy Rating on Five Below (FIVE)